li sheng li - Net Worth and Insider Trading

li sheng li Net Worth

The estimated net worth of li sheng li is at least $493,900 dollars as of 2024-06-21. li sheng li is the senior management of Shanghai Fosun Pharmaceutical (Group) Co Ltd and owns about 22,000 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) stock worth over $493,900. Details can be seen in li sheng li's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that li sheng li has not made any transactions after 2022-09-16 and currently still holds the listed stock(s).

Transaction Summary of li sheng li

To

li sheng li Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, li sheng li owns 1 companies in total, including Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) .

Click here to see the complete history of li sheng li’s form 4 insider trades.

Insider Ownership Summary of li sheng li

Ticker Comapny Transaction Date Type of Owner
SHSE:600196 Shanghai Fosun Pharmaceutical (Group) Co Ltd 2022-09-16 senior management

li sheng li Latest Holdings Summary

li sheng li currently owns a total of 1 stock. li sheng li owns 22,000 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) as of September 16, 2022, with a value of $493,900.

Latest Holdings of li sheng li

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SHSE:600196 Shanghai Fosun Pharmaceutical (Group) Co Ltd 2022-09-16 22,000 22.45 493,900

Holding Weightings of li sheng li


li sheng li Form 4 Trading Tracker

According to the SEC Form 4 filings, li sheng li has made a total of 5 transactions in Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Shanghai Fosun Pharmaceutical (Group) Co Ltd is the acquisition of 100 shares on September 16, 2022, which cost li sheng li around $3,318.

Insider Trading History of li sheng li

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

li sheng li Trading Performance

GuruFocus tracks the stock performance after each of li sheng li's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by li sheng li is 13.19%. GuruFocus also compares li sheng li's trading performance to market benchmark return within the same time period. The performance of stocks bought by li sheng li within 3 months outperforms 5 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how li sheng li's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of li sheng li

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -9.36 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -0.95 LIMIT LIMIT LIMIT LIMIT LIMIT

li sheng li Ownership Network

Ownership Network List of li sheng li

No Data

Ownership Network Relation of li sheng li

Insider Network Chart

li sheng li Owned Company Details

What does Shanghai Fosun Pharmaceutical (Group) Co Ltd do?

Who are the key executives at Shanghai Fosun Pharmaceutical (Group) Co Ltd?

li sheng li is the senior management of Shanghai Fosun Pharmaceutical (Group) Co Ltd. Other key executives at Shanghai Fosun Pharmaceutical (Group) Co Ltd include senior management bao qin gui , senior management Mei Jing Ping , and senior management feng rong li .

Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Shanghai Fosun Pharmaceutical (Group) Co Ltd Insider Transactions

No Available Data

li sheng li Mailing Address

Above is the net worth, insider trading, and ownership report for li sheng li. Currently GuruFocus does not have mailing address information for li sheng li.

Discussions on li sheng li

No discussions yet.